Joy Schechtman

Arthritis Foundation — United States

Medicine · Health Sciences

12h-index2.4kcitations24works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Rheumatoid Arthritis Research and Therapies(15), Chronic Lymphocytic Leukemia Research(8), Lymphoma Diagnosis and Treatment(6), Systemic Lupus Erythematosus Research(6), Monoclonal and Polyclonal Antibodies Research(5)

Publications23 total

Effectiveness and safety of intravenous golimumab with and without concomitant methotrexate in patients with rheumatoid arthritis in the prospective, noninterventional AWARE study
BMC Rheumatology·2023· 4 citedOpen Access
Effectiveness and Safety of Intravenous Golimumab With and Without Concomitant Methotrexate in Patients With Rheumatoid Arthritis in the Prospective, Noninterventional AWARE Study
Research Square (Research Square)·2022Open Access
POS0590 SAFETY AND EFFICACY OF BIOLOGICS IN ELDERLY PATIENTS WITH RHEUMATOID ARTHRITIS IN A REAL WORLD STUDY: USE OF INTRAVENOUS GOLIMUMAB AND INFLIXIMAB IN ADULTS WITH RHEUMATOID ARTHRITIS ≥65 YEARS OF AGE
Annals of the Rheumatic Diseases·2021· 18 cited
SAT0094 UNITED STATES RHEUMATOLOGY PRACTICE-BASED REAL-WORLD EVIDENCE OF METHOTREXATE UTILIZATION AND RESPONSE TO THERAPY IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH INTRAVENOUS GOLIMUMAB
Annals of the Rheumatic Diseases·2019Open Access
A Pulsed Electrical Joint Stimulator for the Treatment of Osteoarthritis of the Hand and Wrist
Orthopedics·2018· 1 cited
Vaccine Responses in Patients with Rheumatoid Arthritis Treated with Certolizumab Pegol: Results from a Single-blind Randomized Phase IV Trial
The Journal of Rheumatology·2014· 78 citedOpen Access
P-146 Assessment of Immune Responses to Pneumococcal and Influenza Vaccines in Patients Receiving Certolizumab Pegol
Inflammatory Bowel Diseases·2014· 1 citedOpen Access
P-146 Assessment of Immune Responses to Pneumococcal and Influenza Vaccines in Patients Receiving Certolizumab Pegol
Inflammatory Bowel Diseases·2013
Synergistic effect of using a transcutaneous electrical joint stimulator and an unloading brace in treating osteoarthritis of the knee.
PubMed·2013· 4 cited
Single- versus dual-infusion of B-cell-depleting antibody ocrelizumab in rheumatoid arthritis: results from the Phase III FEATURE trial
International Journal of Clinical Rheumatology·2011· 5 cited
Denosumab‐mediated increase in hand bone mineral density associated with decreased progression of bone erosion in rheumatoid arthritis patients
Arthritis Care & Research·2010· 122 cited
Safety, Tolerability, and Clinical Outcomes after Intraarticular Injection of a Recombinant Adeno-associated Vector Containing a Tumor Necrosis Factor Antagonist Gene: Results of a Phase 1/2 Study
The Journal of Rheumatology·2009· 109 citedOpen Access
Ocrelizumab, a humanized anti‐CD20 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I/II randomized, blinded, placebo‐controlled, dose‐ranging study
Arthritis & Rheumatism·2008· 203 cited
The immunogenicity, safety, and efficacy of etanercept liquid administered once weekly in patients with rheumatoid arthritis.
PubMed·2007· 144 cited
The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: Results of a phase IIB randomized, double‐blind, placebo‐controlled, dose‐ranging trial
Arthritis & Rheumatism·2006· 1.0k cited
Repeat treatment with rituximab improves physical function and quality of life in patients with rheumatoid arthritis and an inadequate response to tnf inhibitors
2006
Safety and tolerability of rituximab in patients with moderate to severe rheumatoid arthritis: Results from the dose-ranging assessment international clinical evaluation of rituximab in rheumatoid arthritis (DANCER) study
Queensland's institutional digital repository (The University of Queensland)·2005· 16 cited
The safety of anakinra in high‐risk patients with active rheumatoid arthritis: Six‐month observations of patients with comorbid conditions
Arthritis & Rheumatism·2004· 84 cited
Concomitant medication use in a large, international, multicenter, placebo controlled trial of anakinra, a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis.
PubMed·2004· 39 cited
Gastrointestinal Tolerability and Effectiveness of Rofecoxib versus Naproxen in the Treatment of Osteoarthritis
Annals of Internal Medicine·2003· 149 cited
page 1 of 2Next →

Frequent Co-authors

Alan Kivitz(7), Roy Fleischmann(4), Aaron Broadwell(4), Wayne Langholff(4), John Tesser(3), Robert G. Trapp(3), Michele Texter(3), Andreas Fichtner(3), Elliot Chartash(3), Sergio Schwartzman(3), Douglas Conaway(3), Shawn C. Black(3), Stephen Xu(3), Ronald van Vollenhoven(2), Ralph Bennett(2), Dennis Modafferi(2), Edward J. Fudman(2), Wolfgang Dummer(2), Monica Perlman(2), Gunnar Johansson(2)